BIOMAT Database Logo BIOMAT Database Logo

[Nicergoline, an ergot alkaloid, improves ischemic brain damage by ameliorating the decreased cerebral blood flow and metabolism in spontaneously hypertensive rats]. 1992

T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Critical Care Medical Center, Yamaguchi University Hospital, Yamaguchi, Japan.

Effects of ergot alkaloids, nicergoline (NIC), on survival rate, brain water content, local cerebral blood flow (LCBF: 14C-iodoantipyrine) and glucose utilization (LCGU: 14C-2-deoxyglucose) were examined after bilateral carotid artery occlusion (BCAO) in spontaneously hypertensive rats. Two series of study were performed; the permanent BCAO and 3-hr-BCAO study. After permanent BCAO, the survival rate at 24 hrs of 32% (8 mg/kg, i.p.) or 38% (16mg/kg) in NIC group was higher than that in non-treated group (12%). At the end of 3-hr-BCAO, the increase in water content (dry-wet) in di-mesencephalon was less in NIC (100 micrograms/kg/min, i.v.) group than that in non-treated group. The decrease in LCBF in caudate-putamen (CP), parietal cortex (PC), thalamus (TH), hypothalamus (HT), and substantia nigra (SN) were less in NIC group than those in non-treated group. At the 2-hr-reperfusion after 3-hr-BCAO, the decrease in LCBF in TH and HT were less in NIC group than those in non-treated group. The LCGU in sensory motor cortex, CP, PC, HT, inferior colliculus and pons-reticular were higher in NIC group than those in non-treated group. From these results, it is concluded that nicergoline may have ameliorative effects on survival rate related to the prevention of decreased cerebral blood flow and metabolism following brain ischemia.

UI MeSH Term Description Entries
D008297 Male Males
D009530 Nicergoline An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS. Nimergoline,Circo-Maren,Ergobel,F.I. 6714,Fisifax,Nicergobeta,Nicergolin Atid,Nicergolin Lindo,Nicergolin Von Ct,Nicergolin-Neuraxpharm,Nicergolin-Ratiopharm,Nicergolin-TEVA,Nicerium,Nicotergoline,Sermion,Circo Maren,Nicergolin Neuraxpharm,Nicergolin Ratiopharm,Nicergolin TEVA,Von Ct, Nicergolin
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001834 Body Water Fluids composed mainly of water found within the body. Water, Body
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004876 Ergot Alkaloids Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists. Clavine Alkaloids,Alkaloids, Clavine,Alkaloids, Ergot
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Decreased local cerebral blood flow in young and aged spontaneously hypertensive rats.
March 1997, Fukuoka igaku zasshi = Hukuoka acta medica,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Hypercapnic cerebral blood flow in spontaneously hypertensive rats.
October 1998, Journal of hypertension,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Effects of hyperventilation on cerebral blood flow and brain tissue metabolism in normotensive and spontaneously hypertensive rats.
January 1982, Stroke,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Dihydroergotoxine, an ergot alkaloid without marked hypotensive effect, improves blood flow and metabolism in the underperfused canine myocardium.
January 1985, Basic research in cardiology,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Blood-brain barrier, cerebral blood flow, and brain edema in spontaneously hypertensive rats with chronic focal ischemia.
January 1994, Acta neurochirurgica. Supplementum,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Cerebral blood flow distribution and hypoxic-ischemic brain damage in newborn rats.
December 2002, The journal of obstetrics and gynaecology research,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Cerebral blood flow and glucose metabolism of the ischemic rim in spontaneously hypertensive stroke-prone rats with occlusion of the middle cerebral artery.
March 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Inhibition of acetylcholinesterase modulates the autoregulation of cerebral blood flow and attenuates ischemic brain metabolism in hypertensive rats.
September 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
PET O-15 cerebral blood flow and metabolism after acute stroke in spontaneously hypertensive rats.
May 2008, Brain research,
T Ueda, and T Ishikawa, and K Kawata, and K Setoyama, and T Maekawa, and T Sakabe, and H Takeshita
Cerebral glucose utilization and blood flow in adult spontaneously hypertensive rats.
October 1992, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!